Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)
Clinical trial NCT04507204 · TERMINATED
Trial details
- NCT number
- NCT04507204
- Sponsor
- Purdue Pharma LP
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-30
- Primary completion
- 2021-12-22
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.